ARK Investment Management RECURSION PHARMACEUTICALS IN ownership

RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 4 filers reported holding RECURSION PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

ARK Investment Management ownership history of RECURSION PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2022$16,720
-17.4%
2,732,087
-3.4%
0.10%
+17.9%
Q1 2022$20,242
-47.1%
2,827,163
+26.7%
0.08%
-27.6%
Q4 2021$38,234
-35.9%
2,232,013
-13.9%
0.12%
-18.9%
Q3 2021$59,684
-31.3%
2,593,836
+9.0%
0.14%
-11.7%
Q2 2021$86,8222,378,6750.16%